REGN logo

REGN Selling, general & administrative expenses

annual SGA:

$2.95B+$323.10M(+12.28%)
December 31, 2024

Summary

  • As of today (June 2, 2025), REGN annual SGA is $2.95 billion, with the most recent change of +$323.10 million (+12.28%) on December 31, 2024.
  • During the last 3 years, REGN annual SGA has risen by +$1.13 billion (+61.89%).
  • REGN annual SGA is now at all-time high.

Performance

REGN SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

quarterly SGA:

$633.00M-$159.20M(-20.10%)
March 31, 2025

Summary

  • As of today (June 2, 2025), REGN quarterly SGA is $633.00 million, with the most recent change of -$159.20 million (-20.10%) on March 31, 2025.
  • Over the past year, REGN quarterly SGA has dropped by -$56.00 million (-8.13%).
  • REGN quarterly SGA is now -20.10% below its all-time high of $792.20 million, reached on December 31, 2024.

Performance

REGN quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

TTM SGA:

$124.23B+$4.40B(+3.67%)
March 31, 2025

Summary

  • As of today (June 2, 2025), REGN TTM SGA is $124.23 billion, with the most recent change of +$4.40 billion (+3.67%) on March 31, 2025.
  • Over the past year, REGN TTM SGA has increased by +$121.51 billion (+4468.52%).
  • REGN TTM SGA is now at all-time high.

Performance

REGN TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

REGN Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.3%-8.1%+4468.5%
3 y3 years+61.9%+40.7%+6545.6%
5 y5 years+120.2%+72.3%+8660.1%

REGN Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+61.9%-20.1%+40.7%at high+75.6%
5 y5-yearat high+120.2%-20.1%+108.6%at high+345.4%
alltimeall timeat high>+9999.0%-20.1%>+9999.0%at high+2627.1%

REGN Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$633.00M(-20.1%)
$2.90B(-1.9%)
Dec 2024
$2.95B(+12.3%)
$792.20M(+10.9%)
$2.95B(+1.9%)
Sep 2024
-
$714.40M(-5.9%)
$2.90B(+2.6%)
Jun 2024
-
$758.80M(+10.1%)
$2.83B(+3.9%)
Mar 2024
-
$689.00M(-6.6%)
$2.72B(+3.3%)
Dec 2023
$2.63B(+24.4%)
$737.70M(+15.2%)
$2.63B(+3.0%)
Sep 2023
-
$640.50M(-1.8%)
$2.55B(+4.6%)
Jun 2023
-
$652.00M(+8.5%)
$2.44B(+7.8%)
Mar 2023
-
$601.10M(-9.0%)
$2.27B(+7.1%)
Dec 2022
$2.12B(+15.9%)
$660.50M(+24.8%)
$2.12B(+5.0%)
Sep 2022
-
$529.10M(+11.1%)
$2.02B(+4.4%)
Jun 2022
-
$476.30M(+5.8%)
$1.93B(+3.3%)
Mar 2022
-
$450.00M(-19.6%)
$1.87B(+2.4%)
Dec 2021
$1.82B(+35.6%)
$559.60M(+25.8%)
$1.82B(+16.3%)
Sep 2021
-
$445.00M(+7.3%)
$1.57B(+8.1%)
Jun 2021
-
$414.70M(+2.2%)
$1.45B(+4.8%)
Mar 2021
-
$405.60M(+33.6%)
$1.38B(+2.8%)
Dec 2020
$1.35B(+0.3%)
$303.50M(-7.2%)
$1.35B(-9.9%)
Sep 2020
-
$326.90M(-6.1%)
$1.49B(+1.5%)
Jun 2020
-
$348.30M(-5.2%)
$1.47B(+3.8%)
Mar 2020
-
$367.30M(-18.7%)
$1.42B(+5.7%)
Dec 2019
$1.34B(+19.0%)
$451.80M(+48.4%)
$1.34B(+40.9%)
Sep 2019
-
$304.40M(+3.3%)
$952.40M(-6.4%)
Jun 2019
-
$294.60M(+1.2%)
$1.02B(-6.5%)
Mar 2019
-
$291.10M(+367.3%)
$1.09B(-3.5%)
Dec 2018
$1.13B(-14.6%)
$62.30M(-83.1%)
$1.13B(-23.6%)
Sep 2018
-
$369.20M(+1.2%)
$1.47B(+4.4%)
Jun 2018
-
$364.80M(+10.3%)
$1.41B(+4.3%)
Mar 2018
-
$330.80M(-19.3%)
$1.35B(+2.6%)
Dec 2017
$1.32B(+12.1%)
$409.88M(+33.6%)
$1.32B(+6.8%)
Sep 2017
-
$306.77M(-0.0%)
$1.24B(+3.1%)
Jun 2017
-
$306.91M(+3.4%)
$1.20B(+1.3%)
Mar 2017
-
$296.85M(-8.9%)
$1.18B(+0.6%)
Dec 2016
$1.18B(+40.4%)
$325.94M(+20.7%)
$1.18B(+2.7%)
Sep 2016
-
$270.05M(-7.5%)
$1.15B(+5.5%)
Jun 2016
-
$292.04M(+0.8%)
$1.09B(+12.1%)
Mar 2016
-
$289.68M(-1.8%)
$969.21M(+15.6%)
Dec 2015
$838.53M(+61.5%)
$294.95M(+40.5%)
$838.53M(+16.6%)
Sep 2015
-
$209.99M(+20.3%)
$718.88M(+10.1%)
Jun 2015
-
$174.59M(+9.8%)
$652.89M(+13.5%)
Mar 2015
-
$158.99M(-9.3%)
$575.03M(+10.7%)
Dec 2014
$519.27M(+49.9%)
$175.31M(+21.7%)
$519.27M(+17.2%)
Sep 2014
-
$144.00M(+48.9%)
$443.02M(+11.7%)
Jun 2014
-
$96.73M(-6.3%)
$396.63M(+6.5%)
Mar 2014
-
$103.23M(+4.2%)
$372.36M(+7.5%)
Dec 2013
$346.39M(+64.4%)
$99.06M(+1.5%)
$346.39M(+13.5%)
Sep 2013
-
$97.61M(+34.7%)
$305.07M(+19.9%)
Jun 2013
-
$72.46M(-6.2%)
$254.34M(+10.8%)
Mar 2013
-
$77.26M(+33.8%)
$229.59M(+8.9%)
Dec 2012
$210.75M(+79.7%)
$57.74M(+23.2%)
$210.75M(+11.3%)
Sep 2012
-
$46.88M(-1.7%)
$189.37M(+8.0%)
Jun 2012
-
$47.70M(-18.4%)
$175.40M(+15.2%)
Mar 2012
-
$58.43M(+60.7%)
$152.28M(+29.9%)
Dec 2011
$117.26M(+79.8%)
$36.35M(+10.4%)
$117.26M(+15.5%)
Sep 2011
-
$32.92M(+33.9%)
$101.55M(+20.5%)
Jun 2011
-
$24.59M(+5.0%)
$84.30M(+13.3%)
Mar 2011
-
$23.41M(+13.4%)
$74.39M(+14.1%)
Dec 2010
$65.20M(+23.2%)
$20.64M(+31.8%)
$65.20M(+5.9%)
Sep 2010
-
$15.66M(+6.7%)
$61.59M(+4.8%)
Jun 2010
-
$14.68M(+3.2%)
$58.77M(+5.5%)
Mar 2010
-
$14.22M(-16.5%)
$55.73M(+5.3%)
Dec 2009
$52.92M(+8.3%)
$17.03M(+32.6%)
$52.92M(+8.2%)
Sep 2009
-
$12.84M(+10.4%)
$48.91M(+3.1%)
Jun 2009
-
$11.63M(+1.9%)
$47.44M(-3.8%)
Mar 2009
-
$11.42M(-12.3%)
$49.31M(+0.8%)
Dec 2008
$48.88M
$13.02M(+14.6%)
$48.91M(+3.3%)
Sep 2008
-
$11.37M(-15.8%)
$47.33M(+4.6%)
Jun 2008
-
$13.49M(+22.4%)
$45.25M(+11.2%)
DateAnnualQuarterlyTTM
Mar 2008
-
$11.02M(-3.6%)
$40.69M(+7.5%)
Dec 2007
$37.87M(+46.2%)
$11.44M(+23.1%)
$37.87M(+11.2%)
Sep 2007
-
$9.29M(+4.0%)
$34.05M(+10.6%)
Jun 2007
-
$8.94M(+8.9%)
$30.78M(+9.4%)
Mar 2007
-
$8.20M(+7.5%)
$28.15M(+8.7%)
Dec 2006
$25.89M(+1.6%)
$7.63M(+26.7%)
$25.89M(+2.9%)
Sep 2006
-
$6.02M(-4.4%)
$25.16M(-0.8%)
Jun 2006
-
$6.30M(+5.9%)
$25.36M(+0.3%)
Mar 2006
-
$5.95M(-13.8%)
$25.28M(-0.8%)
Dec 2005
$25.48M(+49.3%)
$6.89M(+10.9%)
$25.48M(+8.7%)
Sep 2005
-
$6.22M(+0.0%)
$23.43M(+9.5%)
Jun 2005
-
$6.22M(+1.1%)
$21.40M(+10.2%)
Mar 2005
-
$6.15M(+26.6%)
$19.42M(+13.8%)
Dec 2004
$17.06M(+15.4%)
$4.85M(+16.0%)
$17.06M(+3.7%)
Sep 2004
-
$4.18M(-1.2%)
$16.45M(+3.7%)
Jun 2004
-
$4.24M(+11.7%)
$15.86M(+4.9%)
Mar 2004
-
$3.79M(-10.5%)
$15.12M(+2.2%)
Dec 2003
$14.79M(+18.0%)
$4.24M(+17.7%)
$14.79M(+6.3%)
Sep 2003
-
$3.60M(+3.2%)
$13.91M(+6.0%)
Jun 2003
-
$3.49M(+0.8%)
$13.12M(+4.2%)
Mar 2003
-
$3.46M(+2.8%)
$12.59M(+0.5%)
Dec 2002
$12.53M(+30.4%)
$3.37M(+19.7%)
$12.53M(+5.3%)
Sep 2002
-
$2.81M(-4.9%)
$11.90M(+3.0%)
Jun 2002
-
$2.96M(-13.1%)
$11.55M(+5.2%)
Mar 2002
-
$3.40M(+24.5%)
$10.98M(+14.3%)
Dec 2001
$9.61M(+15.6%)
$2.73M(+11.0%)
$9.61M(-2.9%)
Sep 2001
-
$2.46M(+3.3%)
$9.89M(+7.5%)
Jun 2001
-
$2.38M(+17.3%)
$9.20M(+7.5%)
Mar 2001
-
$2.03M(-32.7%)
$8.56M(-10.4%)
Dec 2000
$8.31M(+29.8%)
$3.02M(+70.7%)
$9.55M(+16.0%)
Sep 2000
-
$1.77M(+1.6%)
$8.24M(+2.1%)
Jun 2000
-
$1.74M(-42.5%)
$8.07M(+3.1%)
Mar 2000
-
$3.03M(+78.0%)
$7.83M(+5.8%)
Dec 1999
$6.40M(+10.3%)
$1.70M(+6.3%)
$7.40M(+4.2%)
Sep 1999
-
$1.60M(+6.7%)
$7.10M(+4.4%)
Jun 1999
-
$1.50M(-42.3%)
$6.80M(-2.9%)
Mar 1999
-
$2.60M(+85.7%)
$7.00M(+20.7%)
Dec 1998
$5.80M(0.0%)
$1.40M(+7.7%)
$5.80M(+3.6%)
Sep 1998
-
$1.30M(-23.5%)
$5.60M(-1.8%)
Jun 1998
-
$1.70M(+21.4%)
$5.70M(0.0%)
Mar 1998
-
$1.40M(+16.7%)
$5.70M(-1.7%)
Dec 1997
$5.80M(-1.7%)
$1.20M(-14.3%)
$5.80M(-3.3%)
Sep 1997
-
$1.40M(-17.6%)
$6.00M(0.0%)
Jun 1997
-
$1.70M(+13.3%)
$6.00M(-52.8%)
Mar 1997
-
$1.50M(+7.1%)
$12.70M(0.0%)
Dec 1996
$5.90M(+1.7%)
$1.40M(0.0%)
$12.70M(+1.6%)
Sep 1996
-
$1.40M(-83.3%)
$12.50M(0.0%)
Jun 1996
-
$8.40M(+460.0%)
$12.50M(+119.3%)
Mar 1996
-
$1.50M(+25.0%)
$5.70M(-1.7%)
Dec 1995
$5.80M(-31.8%)
$1.20M(-14.3%)
$5.80M(-18.3%)
Sep 1995
-
$1.40M(-12.5%)
$7.10M(-7.8%)
Jun 1995
-
$1.60M(0.0%)
$7.70M(-8.3%)
Mar 1995
-
$1.60M(-36.0%)
$8.40M(-1.2%)
Dec 1994
$8.50M(-81.6%)
$2.50M(+25.0%)
$8.50M(-82.2%)
Sep 1994
-
$2.00M(-13.0%)
$47.70M(+0.8%)
Jun 1994
-
$2.30M(+35.3%)
$47.30M(-14.6%)
Mar 1994
-
$1.70M(-95.9%)
$55.40M(-13.8%)
Dec 1993
$46.30M(+66.5%)
$41.70M(+2506.3%)
$64.30M(+111.5%)
Sep 1993
-
$1.60M(-84.6%)
$30.40M(-16.3%)
Jun 1993
-
$10.40M(-1.9%)
$36.30M(+13.1%)
Mar 1993
-
$10.60M(+35.9%)
$32.10M(+15.5%)
Dec 1992
$27.80M(+742.4%)
$7.80M(+4.0%)
$27.80M(+36.3%)
Sep 1992
-
$7.50M(+21.0%)
$20.40M(+38.8%)
Jun 1992
-
$6.20M(-1.6%)
$14.70M(+61.5%)
Mar 1992
-
$6.30M(+1475.0%)
$9.10M(+225.0%)
Dec 1991
$3.30M(+94.1%)
$400.00K(-77.8%)
$2.80M(+16.7%)
Sep 1991
-
$1.80M(+200.0%)
$2.40M(+300.0%)
Jun 1991
-
$600.00K
$600.00K
Dec 1990
$1.70M
-
-

FAQ

  • What is Regeneron Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual SGA year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly SGA year-on-year change?
  • What is Regeneron Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals TTM SGA year-on-year change?

What is Regeneron Pharmaceuticals annual SGA?

The current annual SGA of REGN is $2.95B

What is the all time high annual SGA for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual SGA is $2.95B

What is Regeneron Pharmaceuticals annual SGA year-on-year change?

Over the past year, REGN annual SGA has changed by +$323.10M (+12.28%)

What is Regeneron Pharmaceuticals quarterly SGA?

The current quarterly SGA of REGN is $633.00M

What is the all time high quarterly SGA for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly SGA is $792.20M

What is Regeneron Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, REGN quarterly SGA has changed by -$56.00M (-8.13%)

What is Regeneron Pharmaceuticals TTM SGA?

The current TTM SGA of REGN is $124.23B

What is the all time high TTM SGA for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high TTM SGA is $124.23B

What is Regeneron Pharmaceuticals TTM SGA year-on-year change?

Over the past year, REGN TTM SGA has changed by +$121.51B (+4468.52%)
On this page